HEATHER GRIMMETT: Open Payments
NPI 1073792586 · BLACKFOOT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$348 in 17 payments from 11 companies in 2025. Trend: 2023 $488 · 2024 $564 · 2025 $348
Food & beverage: $348
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| IMMUNITYBIO, INC. | 2 | $43 |
| Laborie Medical Technologies Corp. | 2 | $32 |
| UROGEN PHARMA, INC. | 1 | $29 |
| Olympus America Inc. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: GEMTESA, BOTOX, ANKTIVA, URETERO-RENO VIDEOSCOPE, XTANDI, EndoSheath Technology, Nubeqa, ADSTILADRIN.
Industry payments across ID — which companies pay providers there.
